Edition:
United Kingdom

Express Scripts Holding Co (ESRX.OQ)

ESRX.OQ on NASDAQ Stock Exchange Global Select Market

71.55USD
15 Dec 2017
Change (% chg)

$2.53 (+3.67%)
Prev Close
$69.02
Open
$71.25
Day's High
$72.11
Day's Low
$68.78
Volume
5,024,577
Avg. Vol
1,363,175
52-wk High
$73.38
52-wk Low
$55.80

Chart for

About

Express Scripts Holding Company is a pharmacy benefit management (PBM) company. The Company is engaged in providing healthcare management and administration services to its clients, including managed care organizations, health insurers, third-party administrators, employers, union-sponsored benefit plans, workers' compensation... (more)

Overall

Beta: 0.88
Market Cap(Mil.): $36,015.96
Shares Outstanding(Mil.): 577.55
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 21.41 16.44
EPS (TTM): -- -- --
ROI: -- 11.88 10.62
ROE: -- 13.57 14.20

BRIEF-Express Scripts Holding Sees FY 2017 ADJ SHR $7.00 To $7.08

* EXPRESS SCRIPTS HOLDING COMPANY UPDATES 2017 FULL-YEAR GUIDANCE AND ANNOUNCES 2018 FINANCIAL GUIDANCE

14 Dec 2017

Express Scripts forecast 2018 profit above estimates, shares rise

Pharmacy benefit manager Express Scripts Holding Co forecast full-year 2018 adjusted earnings on Thursday that topped analysts' expectations, helped by its ongoing acquisition of eviCore Healthcare.

14 Dec 2017

UPDATE 1-Express Scripts forecast 2018 profit above estimates, shares rise

Dec 14 Pharmacy benefit manager Express Scripts Holding Co forecast full-year 2018 adjusted earnings on Thursday that topped analysts' expectations, helped by its ongoing acquisition of eviCore Healthcare.

14 Dec 2017

Express Scripts 2018 earnings forecast above estimates

Dec 14 Pharmacy benefit manager Express Scripts Holding Co forecast full-year 2018 adjusted earnings on Thursday that topped analysts' expectations, helped by its ongoing acquisition of eviCore Healthcare.

14 Dec 2017

Deals of the day-Mergers and acquisitions

Nov 30 The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Thursday:

30 Nov 2017

Express Scripts CEO sees Amazon as a potential partner: CNBC

Express Scripts Holding sees Amazon.com Inc , which has been reported to be interested in entering the pharmacy market, as a possible partner rather than a competitor, the chief executive of the pharmacy benefit manager (PBM) said on Thursday on CNBC.

30 Nov 2017

UPDATE 1-Express Scripts CEO sees Amazon as a potential partner-CNBC

Nov 30 Express Scripts Holding sees Amazon.com Inc, which has been reported to be interested in entering the pharmacy market, as a possible partner rather than a competitor, the chief executive of the pharmacy benefit manager (PBM) said on Thursday on CNBC.

30 Nov 2017

Express Scripts CEO says he sees Amazon as a potential partner -CNBC

NEW YORK, Nov 30 Express Scripts Holding chief executive officer said on Thursday on CNBC that he sees Amazon Inc, which has been reported to be interested in entering the pharmacy market, as a possible partner for the pharmacy benefit manager rather than an outright competitor.

30 Nov 2017

BRIEF-Avista Capital Partners To Acquire Express Scripts' Subsidiary United Biosource

* AVISTA CAPITAL PARTNERS TO ACQUIRE EXPRESS SCRIPTS' SUBSIDIARY UNITED BIOSOURCE

27 Nov 2017

BRIEF-Express Scripts Holding files preliminary prospectus supplement related to potential three-part senior notes offering‍​‍​

* Express Scripts Holding Co files preliminary prospectus supplement related to a potential three-part senior notes offering - sec filing‍​‍​ Source text - http://bit.ly/2Af8DkJ Further company coverage:

20 Nov 2017

Competitors

Earnings vs. Estimates